Trials / Completed
CompletedNCT00186069
Magnesium Sulfate vs Placebo for Placental Abruption
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.
Detailed description
We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | Magnesium Sulfate 4 gram bolus, followed by a maintenance dose at 2 grams per hour. Rate increases up to 4 grams per hour may be administered per physician discretion. |
| OTHER | Normal Saline | Normal Saline infusion of 4 gram bolus, followed by 2 grams per hour with rate increases up to 4 grams per hour per physician discretion. |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2014-06-01
- Completion
- 2017-11-01
- First posted
- 2005-09-16
- Last updated
- 2018-01-02
- Results posted
- 2017-04-20
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00186069. Inclusion in this directory is not an endorsement.